These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21099435)

  • 21. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.
    Cai Y; Chai D; Wang R; Liang B; Bai N
    J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of parenteral colistin for the treatment of multiresistant Gram-negative organisms in major burn patients in South Korea.
    Cho YS; Yim H; Yang HT; Hur J; Chun W; Kim JH; Lee BC; Seo DK; Park JM; Kim D
    Infection; 2012 Feb; 40(1):27-33. PubMed ID: 21898119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections.
    Phee LM; Betts JW; Bharathan B; Wareham DW
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4544-50. PubMed ID: 25987639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of colistin in a pediatric burn unit in Argentina.
    Rosanova M; Epelbaum C; Noman A; Villasboas M; Alvarez V; Berberian G; Sberna N; Mudryck G; Lede R
    J Burn Care Res; 2009; 30(4):612-5. PubMed ID: 19506496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection.
    Chen Z; Chen Y; Fang Y; Wang X; Chen Y; Qi Q; Huang F; Xiao X
    Sci Rep; 2015 Nov; 5():17091. PubMed ID: 26597507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial.
    Durante-Mangoni E; Signoriello G; Andini R; Mattei A; De Cristoforo M; Murino P; Bassetti M; Malacarne P; Petrosillo N; Galdieri N; Mocavero P; Corcione A; Viscoli C; Zarrilli R; Gallo C; Utili R
    Clin Infect Dis; 2013 Aug; 57(3):349-58. PubMed ID: 23616495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of intravenous colistin use for the treatment of nosocomial multidrug-resistant Acinetobacter baumannii infections in a pediatric intensive care unit.
    İşgüder R; Ağın H; Ceylan G; Bayram N; Devrim İ
    Am J Infect Control; 2016 Jun; 44(6):734-5. PubMed ID: 26921012
    [No Abstract]   [Full Text] [Related]  

  • 28. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Kwa AL; Loh C; Low JG; Kurup A; Tam VH
    Clin Infect Dis; 2005 Sep; 41(5):754-7. PubMed ID: 16080101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous colistin for the treatment of multi-drug resistant, gram-negative infection in the pediatric burn population.
    Goverman J; Weber JM; Keaney TJ; Sheridan RL
    J Burn Care Res; 2007; 28(3):421-6. PubMed ID: 17438490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
    Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of Acinetobacter baumannii infection in critically ill surgical patients.
    Trottier V; Namias N; Pust DG; Nuwayhid Z; Manning R; Marttos AC; Dunham MB; Schulman CI; McKenney MG
    Surg Infect (Larchmt); 2007 Aug; 8(4):437-43. PubMed ID: 17883360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii.
    Motaouakkil S; Charra B; Hachimi A; Nejmi H; Benslama A; Elmdaghri N; Belabbes H; Benbachir M
    J Infect; 2006 Oct; 53(4):274-8. PubMed ID: 16442632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU.
    Kallel H; Bahloul M; Hergafi L; Akrout M; Ketata W; Chelly H; Hamida CB; Rekik N; Hammami A; Bouaziz M
    Int J Antimicrob Agents; 2006 Oct; 28(4):366-9. PubMed ID: 16971093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin.
    Ho YH; Wang LS; Chao HJ; Chang KC; Su CF
    J Microbiol Immunol Infect; 2007 Dec; 40(6):537-40. PubMed ID: 18087636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.
    Khawcharoenporn T; Pruetpongpun N; Tiamsak P; Rutchanawech S; Mundy LM; Apisarnthanarak A
    Int J Antimicrob Agents; 2014 Apr; 43(4):378-82. PubMed ID: 24613422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
    Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C
    Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of clinical and microbiological efficacy of antibiotic regimens against Acinetobacter baumannii.
    Ackerman BH; Haith LR; Patton ML; Guilday RE; Reigart CL; Stair-Buchmann M
    J Burn Care Res; 2013; 34(4):403-12. PubMed ID: 23237825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colistin against colistin-only-susceptible Acinetobacter baumannii-related infections: Monotherapy or combination therapy?
    Simsek F; Gedik H; Yildirmak MT; Iris NE; Türkmen A; Ersoy A; Ersöz M; Gücüyener A
    Indian J Med Microbiol; 2012; 30(4):448-52. PubMed ID: 23183471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: pharmacodynamic and microbiological aspects.
    Candel FJ; Calvo N; Head J; Sánchez A; Matesanz M; Culebras E; Barrientos A; Picazo J
    Rev Esp Quimioter; 2010 Jun; 23(2):103-8. PubMed ID: 20559610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.